Mepact-type DOPS/POPC liposomal mifamurtide
Anionic DOPS/POPC 3:7 multilamellar liposomes with 1 g total lipid and 4 mg MTP-PE per vial.
Applicable scenario
Composition reference for anionic phosphatidylserine-containing liposomes and immune-cell-directed mifamurtide research. Complements neutral and cationic liposome examples.
Import to Workspace
Open or scan to import into Workspace, jump to Modules and open this Recipe in the editor.
Formulation tables
Anionic liposome composition
| Component / parameter | Value | Context |
|---|---|---|
| DOPS | 30 mol% | Anionic phosphatidylserine lipid |
| POPC | 70 mol% | Phosphatidylcholine lipid |
| Total lipid | 1 g per vial | Reviewed vial composition |
| MTP-PE | 4 mg per vial | Mifamurtide |
| Vesicle form | Multilamellar vesicles <100 nm | Reviewed formulation |
Source values and calculations
- DOPS:POPC is 3:7 mol:mol.
- Each reviewed vial contains 1 g total lipid and 4 mg MTP-PE.
- The source describes multilamellar vesicles below 100 nm; no laboratory production scale is inferred from the vial composition.
Literature source
Bulbake U et al. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics 9, 12 (2017).
Source locator: Table 1 and Section 3.1.5, Mepact
Read the original source · DOI: 10.3390/pharmaceutics9020012
Editorial source check: 2026-11-09. Verify the original publication, actual stock concentrations and local safety requirements before use. Research use only; not clinical instructions.